Pharmacokinetic (PK) and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma (HCC)
| العنوان: | Pharmacokinetic (PK) and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma (HCC) |
|---|---|
| المؤلفون: | E. Schleyer, Florian Eckel, C. Lersch, M. Dobritz, S. von Delius, C Hosius, RM Schmid, Falko Fend, E Schulte-Frohlinde |
| المصدر: | Journal of Clinical Oncology. 23:4135-4135 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2005. |
| سنة النشر: | 2005 |
| مصطلحات موضوعية: | Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, biology, business.industry, medicine.medical_treatment, Advanced stage, Impaired liver function, Imatinib, medicine.disease, digestive system diseases, Pharmacokinetics, Hepatocellular carcinoma, Internal medicine, medicine, biology.protein, In patient, business, Platelet-derived growth factor receptor, medicine.drug |
| الوصف: | 4135 Background: While HCC is one of the most common cancers worldwide, no effective chemotherapy for advanced stages exists. Expression of PDGF receptor has been demonstrated on some hepatoma cell... |
| تدمد: | 1527-7755 0732-183X |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::6c23d88c6c7d400a289d4dac4f753e31Test https://doi.org/10.1200/jco.2005.23.16_suppl.4135Test |
| رقم الانضمام: | edsair.doi...........6c23d88c6c7d400a289d4dac4f753e31 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|